- All channels
- Social Media
- Facebook - Brainlab
- Facebook - The Brainlab Tower
Seventh International Novalis Circle Conference Further Establishes Best Practices and Promotes Wider Access to Advanced Stereotactic Radiosurgery Treatments
Leading clinicians share latest scientific insights supporting the broad application of a new generation of radiosurgery tools
CHICAGO, June 13, 2017 - The Seventh International Conference of the Novalis Circle brought together a selective group of two hundred international experts in neurosurgery, radiation oncology and medical physics to share the latest best practices and discuss clinical synergies of precision radiosurgery and surgery. An international faculty of 35 speakers covered clinical and technological advancements, focusing on stereotactic radiosurgery of secondary metastasis in the brain and spine, intra-cranial primary tumors, arteriovenous malformations and functional disorders.
Medicenna's Immunotherapy Phase 2b Trial Underway Using Brainlab Drug Delivery Technology
Glioblastoma patients receive a novel, minimally invasive treatment directly into brain tumor
MUNICH, Germany, June 6, 2017 — Brainlab and Medicenna Therapeutics Corp (the “Company” or “Medicenna”; TSXV “MDNA”) jointly announced today that recurrent Glioblastoma (rGB) patients in a Phase 2b clinical trial of MDNA55, a targeted immunotherapy agent, have been treated at three clinical centers in the United States using innovative drug delivery technology from Brainlab. The investigators used convection enhanced delivery (CED) to inject MDNA55, together with an imaging agent, directly into the tumor. When combined with real-time image guided MRI, CED allows delivery of MDNA55 at high concentrations into the tumor tissue while avoiding exposure to the rest of the body. The current Phase 2b clinical trial plans to enroll 43 adult patients with rGB at leading brain cancer centers in the United States.
Brainlab Chief Financial Officer Joseph Doyle to Retire
MUNICH, May 23, 2017 – Brainlab AG today announced its Chief Financial Officer (CFO) Joseph A. Doyle intends to retire within the next year, after nearly 20 years of service with the company.
Accelerated Adoption of New Radiosurgery Software from Brainlab
Leading institutions around the world upgrade to new generation “Elements”
Munich, May 4, 2017 — Brainlab, a leader in radiosurgery innovation for more than twenty years, has begun to successfully transition institutions in its considerable global install base to its latest planning software, known as Brainlab Elements. These subscription-based, indication-specific software applications add a higher degree of automation and delivery efficiency to planning.
Brainlab Names New Member of Executive Board
JAN MERKER TO JOIN AS CHIEF OPERATING OFFICER
MUNICH, May 2, 2017 –Jan Merker has been appointed to the Executive Board of Brainlab AG as Chief Operating Officer, effective May 1, 2017. He will assume responsibilities for supply chain management, IT, business process engineering, service, facility management and HR.
Brainlab Fosters Advancement and Interdisciplinary Collaboration in Radiosurgery
Novalis User Meetings bring together various disciplines to discuss advancing cancer care
Munich, Thursday, April 13, 2017 — Brainlab, a leader in medical technology, recently held three Novalis User Meetings, in Bonn, Paris and Dublin, bringing together clinical specialists in stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). Over forty speakers from France, Germany, Austria, Switzerland, Canada, Israel, Ireland, Belgium and the United Kingdom were in attendance to discuss technological advancements in radiation oncology and neurosurgery ranging from clinical decision-making to powerful, automated software modules for more individualized treatment planning and delivery.
Digital O.R. – Raising the Bar for Information Integration in the Operating Room
BRAINLAB DISPLAYS DIGITAL INTEGRATION IN THE OPERATING ROOM AT ASSOCIATION OF PERIOPERATIVE REGISTERED NURSES GLOBAL SURGICAL CONFERENCE & EXPO
BOSTON, March 30, 2017 – Today Brainlab showcases its fully integrated Digital O.R. at the Association of Perioperative Registered Nurses (AORN) Global Surgical Conference & Expo in Boston. Over 10,000 perioperative nurses will be in attendance at AORN to learn, network, and discover the latest technological trends. The digital operating room configuration from Brainlab includes Buzz® , the next generation O.R. centralized information hub.
Brainlab Raises Awareness about Radiosurgery for Brain Metastases Patients on World Cancer Day 2017
Medical technology leader highlights stereotactic radiosurgery as alternative to whole brain radiation therapy for patients with multiple brain metastases
Munich, February 3, 2017—In support of World Cancer Day 2017, which aims to bring global attention to cancer, Brainlab, a leader in cancer-fighting technologies, raises awareness about metastatic brain cancer and the revolutionary new methods being used to treat the disease. According to the World Health Organization (WHO), 14 million new cases of cancer are diagnosed every year, with that number expected to rise by 70% over the next two decades. Cancers of the lung, breast, skin, colon and kidney present the highest risk of metastasizing to the brain.
Brainlab and Elekta Celebrate 50th Installation of ExacTrac with Versa HD
Use of combined technologies simplifies the complexities of stereotactic radiosurgery and offers more seamless workflow
MUNICH, JANUARY 11, 2017—Brainlab and Elekta announced today the installation of the 50th fully integrated system at Southampton General Hospital, which consists of Elekta’s Versa HD™ linear accelerator and ExacTrac® X-Ray, patient positioning and monitoring technology by Brainlab. Leading clinical institutions worldwide are increasingly selecting this combined solution for the precise delivery of stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT).
First Japanese Cancer Center to Demonstrate Commitment to Radiotherapy Patient Safety and Treatment Quality with Novalis Certified
Third-party-administered, rigorous and voluntary certification process demonstrates Hiroshima High-Precision Radiotherapy Cancer Center’s ongoing commitment to high standards in radiotherapy delivery
Hiroshima, Japan, January 10, 2017 – Hiroshima High-Precision Radiotherapy Cancer Center (HIPRAC) announced today that it is the first cancer center in Japan to become Novalis® Certified. After a rigorous certification process conducted by a third party panel of experts, HIPRAC received certification of compliance for quality and patient safety standards in radiosurgery. Patients in the Hiroshima area now have another benchmark to measure safety and treatment quality when researching radiation therapy options for cancer treatment.
Experience the Novalis Difference
Steady Suction with Navigated Disposable Biopsy Needle
REDESIGNED FOR IMPROVED HANDLING
The Disposable Biopsy Needle is designed for navigated removal of tissue samples in frameless neurosurgery procedures. The elaborate redesign increases safety and confidence while the pre-calibrated geometry allows for instant navigation.
TRAMs for Neuro-Oncological Decision-Making
NOVEL HIGH-RESOLUTION MRR-BASED METHODOLOGY
Elements TRAMs (Treatment Response Assessment Maps) supports clinicians in differentiating tumor progression from treatment effects, such as radiation necrosis. The novel MRI-based methodology utilizes two acquisitions of standard T1-weighted MRI taken after injection of a contrast agent at both 5 minutes and 60 - 105 minutes. The first series is intelligently subtracted from the second to show the differentiation between contrast clearance and accumulation, the TRAMs. This makes Elements TRAMs an essential tool for neurosurgeons, radiation oncologists and tumor boards to distinguish between tumor and treatment effects.
Insights into the Future of Brainlab in Radiosurgery
WATCH THE VIDEO TO JOIN THE VISION
The year 2016 brought full circle a journey that Brainlab started four years ago: Reinventing our products and ourselves in the radiosurgery market. In 48 months, we’ve created a revolutionary portfolio of completely new products that are simple and granular, à la carte and indication-specific.
Goodbye, Feldkirchen. Hello, Riem!
FROM JANUARY 1, 2017, FIND US AT OUR BRAND NEW HQ
Brainlab has outgrown its office space in Feldkirchen. Starting January 1st, Brainlab will operate out of its new 24,000 m2 facility in Riem at the site of the former Munich airport encompassing the historic control tower, only a few kilometers from its current headquarters.
World Forum for Medicine
VISIT BRAINLAB AT MEDICA 2016
Get an exclusive perspective on the Brainlab Digital O.R. environment and learn how our simplified, state-of-the-art solutions can provide maximized support for operating room workflows.
Neurosurgery Developments in the Treatment of High Grade Gliomas
DISCOVER HOW BRAINLAB TECHNOLOGY CONTINUES TO DEFINE NEW TREATMENT OPPORTUNITIES FOR PATIENTS WITH RECURRENT DISEASE
The Novalis® Circle invites you to join a symposium during the 21st Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO) in Scottsdale. Our event will be hosted in the Dorado Room of the Fairmont Princess Hotel on Friday, November 18th from 5:30 – 7:30 PM.
Experience Innovations in Imaging, Image Review and Planning
VISIT BRAINLAB AT NASS 2016
Join Brainlab for a look at our latest technologies for image review, imaging, navigation and planning at NASS 2016.
Experience the Latest in Image Review, Intraoperative Spine Imaging and Navigation
VISIT BRAINLAB AT EUROSPINE 2016
Join Brainlab for a look at our latest technologies for image review, imaging and navigation at EUROSPINE 2016.
Optimize Planning Processes for Cranial and Spinal Indications
VISIT BRAINLAB AT SFRO 2016
Brainlab will be showcasing the new Elements Cranial and Spine SRS software at this year’s Annual Congress of the French Society of Radiation Oncology (SFRO) in Paris.